Qi Biodesign
Qi Biodesign is a biotechnology company developing next-generation genome editing technologies. Its proprietary SEEDIT platform features advanced tools for precise gene editing, enabling applications in crop breeding and synthetic biology to address global challenges in food security. The company has achieved significant milestones, including receiving biosafety certificates for gene-edited plants.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $75M
Date: 06-Dec-2024
Investors: Beijing Medical and Health Care Industry Investment Fund (Limited Partnership), Beijing Changping Technology Innodevelop Group, Mingzhe Capital, CD Capital
Markets: Biotechnology, Genome Editing, Agriculture, Synthetic Biology
HQ: Beijing, Beijing, China
Founded: 2021
Website: http://www.qi-biodesign.com/
Twitter: https://twitter.com/QiBiodesign
Crunchbase: https://www.crunchbase.com/organization/qihe-biotech-896c
Leave a Comment
Comments
No comments yet.